| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 01/20/2009 | CA2137822C Method for detecting pre-cancerous or cancerous cells using p90 antibodies or probes |
| 01/20/2009 | CA2108473C Heregulins (hrgs) binding proteins of p185erb2 |
| 01/15/2009 | WO2009008821A1 Method for production of recombinant human thrombin `644 |
| 01/15/2009 | WO2009008529A1 Antibody binding specifically to tdp-43 aggregate |
| 01/15/2009 | WO2009008496A1 Anti-hsulf1 antibody |
| 01/15/2009 | WO2009008414A1 Monoclonal antibody having neutralizing activity against mmp13 |
| 01/15/2009 | WO2008148104A8 Novel vlps derived from cells that do not express a viral matrix or core protein |
| 01/15/2009 | WO2008146019A3 Method for baculovirus generation from insect cells in high-troughput plates |
| 01/15/2009 | WO2008137762A3 Methods of diagnosis and treatment of crohn's disease |
| 01/15/2009 | US20090019608 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 01/15/2009 | US20090018316 Propagating interleukin-15 specific monoclonal antibody for use as tool in controllig immune response |
| 01/15/2009 | US20090018314 low affinity receptor for IgE (FceRII/CD23); for modulating or inhibiting induced IgE expression; allergic conditions, autoimmune and inflammatory diseases |
| 01/15/2009 | US20090018098 Targeting the absence: homozygous dna deletions as signposts for cancer therapy |
| 01/15/2009 | US20090018095 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
| 01/15/2009 | US20090018081 Activatable clostridial toxins |
| 01/15/2009 | US20090018079 Optimized dna and protein sequence of an antibody to improve quality and yield of bacterially expressed antibody fusion proteins |
| 01/15/2009 | US20090018077 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018076 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090018073 Administering polypeptide of growth factor to increase mitogenesis; bind to receptors and increase cell differentiation and survival |
| 01/15/2009 | US20090018071 Epididymis-specific receptor protein |
| 01/15/2009 | US20090018070 Fsh Mutants |
| 01/15/2009 | US20090018068 G-protein coupled receptors |
| 01/15/2009 | US20090017502 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017501 Interferon-alpha polypeptides and conjugates |
| 01/15/2009 | US20090017500 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells; administering antiviral polypeptide |
| 01/15/2009 | US20090017499 Rank ligand-binding polypeptides |
| 01/15/2009 | US20090017498 Fibroblast Growth Factor-Like Polypeptides |
| 01/15/2009 | US20090017496 Co-expression of multiple protein chains or subunits |
| 01/15/2009 | US20090017494 Tick octopamine receptor nucleic acid molecules, proteins and uses thereof |
| 01/15/2009 | US20090017493 Gene SMS 02 |
| 01/15/2009 | US20090017492 SVPH1-26 DNA and polypeptides |
| 01/15/2009 | US20090017490 DNA Fragment Method for Producing Transformant for Protein Production and Utilization Thereof |
| 01/15/2009 | US20090017473 Compositions and methods for the diagnosis and treatment of tumor |
| 01/15/2009 | US20090017162 Neutral cellulase catalytic core and method of producing same |
| 01/15/2009 | US20090017077 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 01/15/2009 | US20090017066 Novel vlps derived from cells that do not express a viral matrix or core protein |
| 01/15/2009 | US20090017044 Antibodies to the Human Prolactin Receptor |
| 01/15/2009 | US20090017039 SP35 Antibodies and uses thereof |
| 01/15/2009 | US20090017037 Human TIMP-1 Antibodies |
| 01/15/2009 | US20090017034 inhibits thymic stromal lymphopoietin TSLP)-mediated lymphocyte stimulation; using these polypeptides as molecular weight markers that allow the estimation of the molecular weight of a protein or a fragmented protein |
| 01/15/2009 | US20090017033 Inhibiting receptor activated nuclear factor kappa beta ligand (RANKL); immunoregulation |
| 01/15/2009 | US20090017030 Endothelial Cell Expression Patterns |
| 01/15/2009 | US20090017020 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 01/15/2009 | US20090017017 Anti-rhesus d recombinant polyclonal antibody and methods of manufacture |
| 01/15/2009 | US20090017014 Compositions and methods for the treatment of immune related diseases |
| 01/15/2009 | US20090017010 Novel artemis/dna-dependent protein kinase complex and methods of use thereof |
| 01/15/2009 | US20090017006 Use of a compound for enhancing the expression of membrane proteins on the cell surface |
| 01/15/2009 | US20090016965 Internal image antibodies for optical imaging and therapy |
| 01/15/2009 | US20090016957 Polypeptides |
| 01/15/2009 | US20090014562 Spray Nozzle Apparatus and Method of Use |
| 01/15/2009 | DE112007000484T5 Stabil isotopenmarkierte aliphatische Aminosäuren, Verfahren zum Einbringen von diesen in ein Zielprotein und Verfahren zur NMR-Konformationsanalyse von Proteinen Stable isotope-labeled aliphatic amino acids, methods for introducing these into a target protein, and NMR method for the conformation of proteins |
| 01/15/2009 | CA2692656A1 Method for production of recombinant human thrombin '644 |
| 01/14/2009 | EP2014770A2 WNT-1 Iinduced secreted polypeptide WISP-2 |
| 01/14/2009 | EP2014677A1 A-33 related antigens and their pharmacological uses |
| 01/14/2009 | EP2014676A1 Hgf precursor protein mutant and activated form thereof |
| 01/14/2009 | EP2014298A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 01/14/2009 | EP2014180A1 Composition useful for the reduction of the cardivascular risk and foods that contain it |
| 01/14/2009 | EP2013357A2 Expression of o-glycosylated therapeutic proteins in prokaryotic microorganisms |
| 01/14/2009 | EP2013356A2 Microwave assisted deglycosylation of proteins for molecular weight determination by mass spectrometry |
| 01/14/2009 | EP2013342A1 Auto- inducible sodium phosphate symporter promoter from pichia pastoris and method for producing recombinant protein using it |
| 01/14/2009 | EP2013340A2 Method for cloning and expression of nrui restriction endonuclease |
| 01/14/2009 | EP1885867A4 Novel methods |
| 01/14/2009 | EP1751289B1 Tc-83-derived alphavirus vectors, particles and methods |
| 01/14/2009 | EP1609858B1 Method for detecting substrates or inhibitors for branched neutral amino acid transporters |
| 01/14/2009 | EP1572967B1 Il-1 receptor based antagonists and methods of making and using |
| 01/14/2009 | EP1456386B1 Polycistronic expression of antibodies in cho cells |
| 01/14/2009 | EP1390389B1 Cripto blocking antibodies and uses thereof |
| 01/14/2009 | EP1360314B1 Chemically defined medium for cultured mammalian cells |
| 01/14/2009 | EP1297142B1 Dual specificity antibodies and methods of making and using |
| 01/14/2009 | EP1187918B2 Tek antagonists |
| 01/14/2009 | EP1144616B2 Method for producing antibody fragments |
| 01/14/2009 | EP1130029B1 Protein amsh and cdna thereof |
| 01/14/2009 | EP1068332B1 Recombinant anti-tumor rnase |
| 01/14/2009 | EP1025218B1 Libraries of human antibody polypetides |
| 01/14/2009 | EP0724594B1 Regulation of transcription factor, nf-il6/lap |
| 01/14/2009 | CN101343653A Preparation method for holothurian collagen active peptide and application thereof |
| 01/14/2009 | CN101343652A Mushroom ferment crude protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343651A Mushroom ferment pure protein with antineoplastic activity, extracting method and formulation |
| 01/14/2009 | CN101343324A Method for the inhibition of human TNF alpha activity |
| 01/14/2009 | CN101343309A Method for simultaneously separating soy protein and oil fat with inverse micelle abstraction technique |
| 01/14/2009 | CN100451127C Peptides with anti-hypertensive properties |
| 01/14/2009 | CN100451126C Process for separating protein, apple polyphenol, apple starch and pigment from apple juice |
| 01/14/2009 | CN100451102C Over-expression of extremozyme genes in pseudomonads and closely related bacteria |
| 01/14/2009 | CN100450543C Animal medicine capable of increasing immunologic function of livestock and birds |
| 01/13/2009 | US7476777 apomictic plant containing a transgene for a desired trait and a transgene causing seed infertility; Seeds that are formed on such plants are infertile |
| 01/13/2009 | US7476731 Variants of the alpha 1 subunit of human AMPK |
| 01/13/2009 | US7476730 Encoding glycosaminoglycan 6-O-sulfotransferase for use in diagnosis of tumor disorders |
| 01/13/2009 | US7476728 Flea GABA receptor subunit nucleic acid molecules |
| 01/13/2009 | US7476723 Nucleotide sequences coding membrane protein ; antiproliferative agents; anticancer agents; antiinflammatory agents |
| 01/13/2009 | US7476722 Chromatography separation using apatite; protein being purified can comprise at least one constant antibody immunoglobulin domain |
| 01/13/2009 | US7476546 Method for single oxygen atom incorporation into digested peptides using peptidases |
| 01/13/2009 | US7476536 Artificial human chromosome containing human antibody a light chain gene |
| 01/13/2009 | US7476529 Fermenting yeast culture and recovering peptides and surface active agent for use in enhancing metabolic rates in biological systems and increasing nutrient uptake of cells; bioremediation and waste water treatment |
| 01/13/2009 | US7476527 Comprises nucleotide sequences coding galactosyltransferase for use in treatment or prevention of aberrant cell surface glycosylation associated with tumor progression |
| 01/13/2009 | US7476526 Protein for use in generating resistance to bactericides in cells |
| 01/13/2009 | US7476525 Modified pyrroloquinoline quinone (PQQ) dependent glucose dehydrogenase with superior substrate specificity and stability |
| 01/13/2009 | US7476524 Comprises nucleotide sequences coding prostaglandin h synthase for treatment of inflammation; antiinflammatory agents; cytoprotective agents |
| 01/13/2009 | US7476518 Nucleic acids encoding fluorescent proteins and methods of using the same |
| 01/13/2009 | US7476516 Methods for producing biological substances in pigment-deficient mutants of Bacillus cells |
| 01/13/2009 | US7476515 Affinity trap reactor and single-step process for purifying angiostatin-like fragment from human plasma using the same |